Healius Limited is an Australian firm dedicated to delivering specialized diagnostic services to both individual consumers and healthcare practitioners. Its operations are structured into four primary segments: Pathology, Medical Imaging, Day Hospitals, and other miscellaneous services. The company's core offerings include comprehensive diagnostic imaging, private medical laboratory analysis, and various pathology services. Furthermore, under a diverse portfolio of brands such as Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetpath Laboratory, Vetnostics, QML Vetnostics, TML Vetnostics, ASAP Laboratory, Abbott Pathology, TML Pathology, IQ, Pathology, Kossard, Gastrolab, and Agilex Biolabs, alongside Lumus Imaging and Montserrat, Healius also facilitates a wide array of specialized surgical procedures. These encompass cataract removal, colonoscopies, gastroscopies, plastic and cosmetic operations, skin cancer excisions, IVF egg collection, and gynecological surgeries. The company boasts an extensive network across Australia, comprising 2,105 pathology facilities, 11 day hospitals, and 134 imaging centers. Established in 1994, the entity was originally known as Primary Health Care Limited, adopting the Healius Limited name in December 2018. Its corporate headquarters are situated in Sydney, Australia.
The current price of PGZ.STU is €0.27 EUR — it has increased by +2.24% in the past 24 hours. Watch Healius Limited stock price performance more closely on the chart.
What is Healius Limited stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Healius Limited stocks are traded under the ticker PGZ.STU.
Is Healius Limited stock price growing?▼
PGZ.STU stock has risen by +15.13% compared to the previous week, the month change is a +16.1% rise, over the last year Healius Limited has showed a -39.11% decrease.
What is Healius Limited market cap?▼
Today Healius Limited has the market capitalization of 198.97M
When is the next Healius Limited earnings date?▼
Healius Limited is going to release the next earnings report on February 24, 2027.
What were Healius Limited earnings last quarter?▼
PGZ.STU earnings for the last quarter are -0 EUR per share, whereas the estimation was 0 EUR resulting in a -370.51% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Healius Limited revenue for the last year?▼
Healius Limited revenue for the last year amounts to 1.23B EUR.
What is Healius Limited net income for the last year?▼
PGZ.STU net income for the last year is -269.11M EUR.
Does Healius Limited pay dividends?▼
Yes, PGZ.STU dividends are paid semi-annual. The last dividend per share was 0.24 EUR. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Healius Limited have?▼
As of September 08, 2026, the company has 6,000 employees.
In which sector is Healius Limited located?▼
Healius Limited operates in the Materials sector.
When did Healius Limited complete a stock split?▼
Healius Limited has not had any recent stock splits.